Swedbank Ab Organon & Co. Transaction History

Swedbank Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Dec 09, 2024	SELL	$21.42 - $32.08 $81,096 - $121,454	-3,786 Closed	0 $0
Q4 2022 Dec 09, 2024	SELL	$23.31 - $28.61 $7,482 - $9,183	-321 Reduced 7.82%	3,786 $105,000
Q2 2022 Dec 09, 2024	SELL	$31.66 - $38.9 $2.41 Million - $2.97 Million	-76,250 Reduced 94.89%	4,107 $138,000
Q4 2021 Dec 09, 2024	SELL	$28.67 - $37.13 $1.73 Million - $2.24 Million	-60,406 Reduced 42.91%	80,357 $2.45 Million
Q3 2021 Dec 09, 2024	SELL	$28.63 - $35.64 $5.3 Million - $6.59 Million	-184,969 Reduced 56.79%	140,763 $4.62 Million
Q2 2021 Dec 09, 2024	BUY	$28.45 - $38.0 $9.27 Million - $12.4 Million	325,732 New	325,732 $9.86 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.85B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.